Parkinson’s, Alzheimer’s, and Dementia Panel
Alzheimer’s disease, Parkinson’s disease, and Dementia are neurological diseases that affect the brain. Some of the symptoms of PD, AD, and Dementia include memory loss, confusion, loss of coordination/motor skills, and depression. Parkinson’s disease can also cause a variety of additional problems, including difficulties with movement, tremors in the hands and limbs, memory loss, and reduced mental functioning (such as problem solving and controlling emotions). As we age, the likelihood of developing conditions like Parkinson’s, Alzheimer’s, and Dementia increases. While some causes of these diseases are still unknown, abnormalities in our genes that have been linked with these diseases can sometimes be inherited from our parents. Studies suggest that people with a family history of Parkinson’s, Alzheimer’s, and Dementia may have a higher probability of developing these conditions. Currently, there is no cure for these diseases; however, medications are available to slow the progression of the disease and
temporarily relieve symptoms.
Genetic testing for PAD can help doctors identify patients who have a higher risk of developing these diseases, allowing them to create a plan to combat the onset and progression of symptoms. This genetic test is appropriate for
people who have experienced any of the following symptoms: abnormal imaging of the brain, difficulty moving or controlling the body, observable intellectual decline that interferes with daily life, and notable memory loss. It is also recommended for people experiencing changes in mood, behavior, impaired language skills, and a decline in the ability to perform daily tasks (like shopping and driving).
Genetic testing for Parkinson’s, Alzheimer’s, and Dementia is minimally invasive, requiring only a simple swab of the inside of the cheek. Results are typically available within 2 to 4 weeks.